Omnicell

JANUARY 10, 2023

Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy.

Sterile Compounds 98

Sterile Compounds Compounding Omnicell Patient Care 98

Omnicell

JANUARY 10, 2023

See how Omnicell is transforming pharmacy care at Booth #1213 in the Exhibit Hall, where you can explore our full portfolio of services for central pharmacy and IV compounding robotics, point-of-care dispensing, inventory optimization, specialty pharmacy, and retail pharmacy. And Omnicell is more than a vendor.

Specialty Pharmacies 89

Specialty Pharmacies Sterile Compounds Omnicell Compounding 89

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

SEPTEMBER 5, 2022

When we talked about IV room compounding, I’ll never forget them telling me, “Making IVs is not like making pizzas at the local sub shop.” ” It’s not a big deal if you mix up sausage and pepperoni on a pizza, but one misstep in manual IV compounding could be absolutely devastating to a patient.

Compounding 52

Compounding Sterile Compounds Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

Many often rely on 503B outsourcing pharmacies for their pre-mixed compounded sterile products. At the University of Maryland Medical Center, we reduced our need for 503B vendors by implementing an IV robotics insourcing program for compounded sterile products (CSPs).

Compounding 52

Compounding Omnicell Sterile Compounds Hospitals 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). Omnicell's IV compounding robot service offered the holistic solution we needed.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

Omnicell 52

Omnicell Sterile Compounds Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

Ken Osborn Senior Director, Product Marketing, Omnicell As medication management continues to be one of the top challenges of healthcare today, Omnicell’s commitment to delivering the innovation to navigate and streamline the complexities of the pharmacy care delivery model is stronger than ever.

Controlled Substances 52

Controlled Substances Omnicell Compounding Sterile Compounds 52

Omnicell

SEPTEMBER 5, 2022

Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. Worst yet, 74% of all respondents were aware of at least one pharmacy compounding error in the last 12 months.

Compounding 52

Compounding Sterile Compounds Documentation Compounding Pharmacies 52

Omnicell

MARCH 27, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52

Omnicell

FEBRUARY 14, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Omnicell is partnering with the Autonomous Pharmacy Advisory Board to transform the pharmacy care model through technology-enabled solutions and delivering expert services, supporting the journey to “zero error” through the Autonomous Pharmacy.

Hospitals 52

Hospitals Sterile Compounds Omnicell Patient Care 52